Literature DB >> 33877716

The scope and severity of white-nose syndrome on hibernating bats in North America.

Tina L Cheng1, Jonathan D Reichard2, Jeremy T H Coleman2, Theodore J Weller3, Wayne E Thogmartin4, Brian E Reichert5, Alyssa B Bennett6, Hugh G Broders7, Joshua Campbell8, Katherine Etchison9, Daniel J Feller10, Richard Geboy11, Traci Hemberger12, Carl Herzog13, Alan C Hicks13, Sandra Houghton14, Jessica Humber15, Joseph A Kath16, R Andrew King11, Susan C Loeb17, Ariane Massé18, Katrina M Morris19, Holly Niederriter20, Gerda Nordquist21, Roger W Perry22, Richard J Reynolds23, D Blake Sasse24, Michael R Scafini25, Richard C Stark26, Craig W Stihler27, Steven C Thomas28, Gregory G Turner25, Shevenell Webb29, Bradley Westrich30, Winifred F Frick1,31.   

Abstract

Assessing the scope and severity of threats is necessary for evaluating impacts on populations to inform conservation planning. Quantitative threat assessment often requires monitoring programs that provide reliable data over relevant spatial and temporal scales, yet such programs can be difficult to justify until there is an apparent stressor. Leveraging efforts of wildlife management agencies to record winter counts of hibernating bats, we collated data for 5 species from over 200 sites across 27 U.S. states and 2 Canadian provinces from 1995 to 2018 to determine the impact of white-nose syndrome (WNS), a deadly disease of hibernating bats. We estimated declines of winter counts of bat colonies at sites where the invasive fungus that causes WNS (Pseudogymnoascus destructans) had been detected to assess the threat impact of WNS. Three species undergoing species status assessment by the U.S. Fish and Wildlife Service (Myotis septentrionalis, Myotis lucifugus, and Perimyotis subflavus) declined by more than 90%, which warrants classifying the severity of the WNS threat as extreme based on criteria used by NatureServe. The scope of the WNS threat as defined by NatureServe criteria was large (36% of Myotis lucifugus range) to pervasive (79% of Myotis septentrionalis range) for these species. Declines for 2 other species (Myotis sodalis and Eptesicus fuscus) were less severe but still qualified as moderate to serious based on NatureServe criteria. Data-sharing across jurisdictions provided a comprehensive evaluation of scope and severity of the threat of WNS and indicated regional differences that can inform response efforts at international, national, and state or provincial jurisdictions. We assessed the threat impact of an emerging infectious disease by uniting monitoring efforts across jurisdictional boundaries and demonstrated the importance of coordinated monitoring programs, such as the North American Bat Monitoring Program (NABat), for data-driven conservation assessments and planning.
© 2021 Society for Conservation Biology.

Entities:  

Keywords:  Endangered Species Act; Ley de Especies en Peligro de Extinción; NatureServe; North American Bat Monitoring Program; Programa de Monitoreo de Murciélagos Norteamericanos; conservación; conservation; data sharing; disease; enfermedad; intercambio de datos; monitoreo; monitoring

Year:  2021        PMID: 33877716     DOI: 10.1111/cobi.13739

Source DB:  PubMed          Journal:  Conserv Biol        ISSN: 0888-8892            Impact factor:   6.560


  13 in total

1.  A comparison of six DNA extraction protocols for 16S, ITS and shotgun metagenomic sequencing of microbial communities.

Authors:  Justin P Shaffer; Carolina S Carpenter; Cameron Martino; Rodolfo A Salido; Jeremiah J Minich; MacKenzie Bryant; Karenina Sanders; Tara Schwartz; Gregory Humphrey; Austin D Swafford; Rob Knight
Journal:  Biotechniques       Date:  2022-06-17       Impact factor: 2.746

2.  The population genetics of the causative agent of snake fungal disease indicate recent introductions to the USA.

Authors:  Jason T Ladner; Jonathan M Palmer; Cassandra L Ettinger; Jason E Stajich; Terence M Farrell; Brad M Glorioso; Becki Lawson; Steven J Price; Anne G Stengle; Daniel A Grear; Jeffrey M Lorch
Journal:  PLoS Biol       Date:  2022-06-23       Impact factor: 9.593

3.  Changes in hibernating tricolored bat (Perimyotis subflavus) roosting behavior in response to white-nose syndrome.

Authors:  Susan C Loeb; Eric A Winters
Journal:  Ecol Evol       Date:  2022-07-06       Impact factor: 3.167

4.  Seasonal roost selection and activity of a remnant population of northern myotis in Pennsylvania.

Authors:  Mattea A Lewis; Gregory G Turner; Michael R Scafini; Joseph S Johnson
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

5.  Disease-related population declines in bats demonstrate non-exchangeability in generalist predators.

Authors:  Amy K Wray; Claudio Gratton; Michelle A Jusino; Jing Jamie Wang; Jade M Kochanski; Jonathan M Palmer; Mark T Banik; Daniel L Lindner; M Zachariah Peery
Journal:  Ecol Evol       Date:  2022-06-06       Impact factor: 3.167

6.  Skin pH varies among bat species and seasons and between wild and captive bats.

Authors:  Karen J Vanderwolf; Christopher J Kyle; Paul A Faure; Donald F McAlpine; Christina M Davy
Journal:  Conserv Physiol       Date:  2021-12-06       Impact factor: 3.079

7.  Biomarker Metabolites Discriminate between Physiological States of Field, Cave and White-nose Syndrome Diseased Bats.

Authors:  Anna C Doty; A Dan Wilson; Lisa B Forse; Thomas S Risch
Journal:  Sensors (Basel)       Date:  2022-01-28       Impact factor: 3.576

8.  Winter torpor expression varies in four bat species with differential susceptibility to white-nose syndrome.

Authors:  Reilly T Jackson; Emma V Willcox; Riley F Bernard
Journal:  Sci Rep       Date:  2022-04-05       Impact factor: 4.379

9.  Emergence activity at hibernacula differs among four bat species affected by white-nose syndrome.

Authors:  Reilly T Jackson; Emma V Willcox; John M Zobel; Riley F Bernard
Journal:  Ecol Evol       Date:  2022-07-13       Impact factor: 3.167

10.  Experimental inoculation trial to determine the effects of temperature and humidity on White-nose Syndrome in hibernating bats.

Authors:  Winifred F Frick; Emily Johnson; Tina L Cheng; Julia S Lankton; Robin Warne; Jason Dallas; Katy L Parise; Jeffrey T Foster; Justin G Boyles; Liam P McGuire
Journal:  Sci Rep       Date:  2022-01-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.